#	Pagina
attuale pagina	/open-h2020/projects/199498/index.html

Opendata, web and dolomites

BILISTICK

BILISTICK: A low cost point-of-care for early diagnosis of hyperbilirubinemia in newborns

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

BILISTICK project word cloud

Explore the words cloud of the BILISTICK project. It provides you a very rough idea of what is the project "BILISTICK" about.

acceptance core applicable post functions plan disease kernicterus converging universal purpose hyperbilirubinemia minimally solutions professional thousands dis union oriented emphasis competitors individualized expensive entrepreneurial blood worst liver measuring bilimetrix largely academic huge healthcare damage of follow consequent rapid viewpoint bilirubin screening pricing technologies off diagnostic examination feasibility acquired portable preventable bilistick aap nature giving invasive marketing discharge severe care consequence permanent mainly team prevent promptly point guidelines biomarkers medical kidney accurate university diagnosis heart put business trieste international neurological economical national device spin innovative vitro recommend solution market company newborns

Project "BILISTICK" data sheet

The following table provides information about the project.

Coordinator	BILIMETRIX SRL Organization address address: AREA SCIENCE PARK ED Q city: TRIESTE postcode: 34149 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Italy [IT]
Project website	http://www.bilimetrix.net
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2015
Funding Scheme	SME-1
Starting year	2016
Duration (year-month-day)	from 2016-02-01 to 2016-07-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	BILIMETRIX SRL BILIMETRIX SRL Organization address address: AREA SCIENCE PARK ED Q city: TRIESTE postcode: 34149 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	IT (TRIESTE)	coordinator	50˙000.00

Map

Project objective

The objective of the overall project is to lead to the international market “Bilistick”, an innovative low-cost Point-of-Care for early diagnosis of hyperbilirubinemia. The system aims to prevent, through early diagnosis, the permanent neurological damage that severe hyperbilirubinemia can cause in newborns.Every year in European Union there are about 3 thousands cases of kernicterus (worst consequence of hyperbilirubinemia) determining consequent huge costs for National Healthcare Systems. Kernicterus is a largely preventable disease if severe hyperbilirubinemia is identified early and promptly treated. For this reason AAP Guidelines (adopted by EU) recommend universal bilirubin screening and individualized post-discharge follow-up care based on results of such screening. However existing solutions are expensive, not portable or not enough accurate. Bilistick is the only in vitro rapid diagnostic device for measuring the level of bilirubin in the blood of newborns. It is low cost, minimally invasive, portable, giving rapid response, accurate and applicable in all newborns. It is the result of experience acquired during years of academic and professional research carried out by the entrepreneurial team of Bilimetrix s.r.l.. Bilimetrix s.r.l. is a spin-off of the University of Trieste, established as a research and development company. Its core business is development of medical devices based on advanced technologies oriented on liver, kidney and heart dis-functions. All solution are mainly based on new biomarkers. The purpose of the feasibility study is a comprehensive examination of all aspects of feasibility of the project, from the technical to the economical viewpoint, converging in a detailed business plan for application in Phase 2. Emphasis will be put on market analysis (nature of the market, type of users, competitors in the market, pricing systems, methods of distribution and marketing) and then on examination of the market acceptance towards Bilistick

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BILISTICK" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BILISTICK" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination